TY - JOUR AU - Gelmon, K. AU - Dent, R. AU - Mackey, J. R. AU - Laing, K. AU - McLeod, D. AU - Verma, S. PY - 2012 DA - 2012// TI - Targeting triple-negative breast cancer: optimising therapeutic outcomes JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mds067 DO - 10.1093/annonc/mds067 ID - Gelmon2012 ER - TY - JOUR AU - Podo, F. AU - Buydens, L. M. AU - Degani, H. AU - Hilhorst, R. AU - Klipp, E. AU - Gribbestad, I. S. AU - Van Huffel, S. AU - van Laarhoven, H. W. AU - Luts, J. AU - Monleon, D. PY - 2010 DA - 2010// TI - Triple-negative breast cancer: present challenges and new perspectives JO - Mol Oncol VL - 4 UR - https://doi.org/10.1016/j.molonc.2010.04.006 DO - 10.1016/j.molonc.2010.04.006 ID - Podo2010 ER - TY - JOUR AU - Walsh, S. AU - Flanagan, L. AU - Quinn, C. AU - Evoy, D. AU - McDermott, E. W. AU - Pierce, A. AU - Duffy, M. J. PY - 2012 DA - 2012// TI - mTOR in breast cancer: differential expression in triple-negative and non-triple-negative tumors JO - Breast VL - 21 UR - https://doi.org/10.1016/j.breast.2011.09.008 DO - 10.1016/j.breast.2011.09.008 ID - Walsh2012 ER - TY - JOUR AU - Shaw, R. J. AU - Cantley, L. C. PY - 2006 DA - 2006// TI - Ras, PI(3)K and mTOR signalling controls tumour cell growth JO - Nature VL - 441 UR - https://doi.org/10.1038/nature04869 DO - 10.1038/nature04869 ID - Shaw2006 ER - TY - JOUR AU - Dancey, J. AU - Sausville, E. A. PY - 2003 DA - 2003// TI - Issues and progress with protein kinase inhibitors for cancer treatment JO - Nat Rev Drug Discov VL - 2 UR - https://doi.org/10.1038/nrd1066 DO - 10.1038/nrd1066 ID - Dancey2003 ER - TY - JOUR AU - Navé, B. T. AU - Ouwens, M. AU - Withers, D. J. AU - Alessi, D. R. AU - Shepherd, P. R. PY - 1999 DA - 1999// TI - Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation JO - Biochem J VL - 344 UR - https://doi.org/10.1042/bj3440427 DO - 10.1042/bj3440427 ID - Navé1999 ER - TY - JOUR AU - Margariti, N. AU - Fox, S. B. AU - Bottini, A. AU - Generali, D. PY - 2011 DA - 2011// TI - “Overcoming breast cancer drug resistance with mTOR inhibitors”. Could it be a myth or a real possibility in the short-term future? JO - Breast Cancer Res Treat VL - 128 UR - https://doi.org/10.1007/s10549-010-0986-9 DO - 10.1007/s10549-010-0986-9 ID - Margariti2011 ER - TY - JOUR AU - Schmelzle, T. AU - Hall, M. N. PY - 2000 DA - 2000// TI - TOR, a central controller of cell growth JO - Cell VL - 103 UR - https://doi.org/10.1016/S0092-8674(00)00117-3 DO - 10.1016/S0092-8674(00)00117-3 ID - Schmelzle2000 ER - TY - JOUR AU - Villarreal-Garza, C. AU - Cortes, J. AU - Andre, F. AU - Verma, S. PY - 2012 DA - 2012// TI - mTOR inhibitors in the management of hormone receptor-positive breast cancer: the latest evidence and future directions JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mds075 DO - 10.1093/annonc/mds075 ID - Villarreal-Garza2012 ER - TY - JOUR AU - Lu, C. H. AU - Wyszomierski, S. L. AU - Tseng, L. M. AU - Sun, M. H. AU - Lan, K. H. AU - Neal, C. L. AU - Mills, G. B. AU - Hortobagyi, G. N. AU - Esteva, F. J. AU - Yu, D. PY - 2007 DA - 2007// TI - Preclinical testing of clinically applicable strategies for overcoming trastuzumab resistance caused by PTEN deficiency JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-2837 DO - 10.1158/1078-0432.CCR-06-2837 ID - Lu2007 ER - TY - JOUR AU - Mabuchi, S. AU - Kawase, C. AU - Altomare, D. A. AU - Morishige, K. AU - Sawada, K. AU - Hayashi, M. AU - Tsujimoto, M. AU - Yamoto, M. AU - Klein-Szanto, A. J. AU - Schilder, R. J. PY - 2009 DA - 2009// TI - mTOR is a promising therapeutic target both in cisplatin-sensitive and cisplatin-resistant clear cell carcinoma of the ovary JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-09-0365 DO - 10.1158/1078-0432.CCR-09-0365 ID - Mabuchi2009 ER - TY - JOUR AU - Alvarez, R. H. AU - Valero, V. AU - Hortobagyi, G. N. PY - 2010 DA - 2010// TI - Emerging targeted therapies for breast cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.25.4011 DO - 10.1200/JCO.2009.25.4011 ID - Alvarez2010 ER - TY - JOUR AU - Carraway, H. AU - Hidalgo, M. PY - 2004 DA - 2004// TI - New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists JO - Breast Cancer Res VL - 6 UR - https://doi.org/10.1186/bcr927 DO - 10.1186/bcr927 ID - Carraway2004 ER - TY - JOUR AU - An, J. AU - Jeong, H. AU - Lee, Y. AU - Woo, S. U. AU - Seo, J. H. AU - Kim, A. PY - 2010 DA - 2010// TI - Phosphorylated Akt and Phosphorylated mTOR Expression in Breast Invasive Carcinomas: Analysis of 530 Cases JO - Journal of Breast Cancer VL - 13 UR - https://doi.org/10.4048/jbc.2010.13.4.337 DO - 10.4048/jbc.2010.13.4.337 ID - An2010 ER - TY - JOUR AU - Wander, S. A. AU - Hennessy, B. T. AU - Slingerland, J. M. PY - 2011 DA - 2011// TI - Next-generation mTOR inhibitors in clinical oncology: how pathway complexity informs therapeutic strategy JO - J Clin Invest VL - 121 UR - https://doi.org/10.1172/JCI44145 DO - 10.1172/JCI44145 ID - Wander2011 ER - TY - JOUR AU - Misdorp, W. AU - Weijer, K. PY - 1980 DA - 1980// TI - Animal model of human disease: breast cancer JO - Am J Pathol VL - 98 ID - Misdorp1980 ER - TY - JOUR AU - Martín De Las Mulas, J. AU - Millán, Y. AU - Bautista, M. AU - Pérez, J. AU - Carrasco, L. PY - 2000 DA - 2000// TI - Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study JO - Res Vet Sci VL - 68 UR - https://doi.org/10.1053/rvsc.1999.0327 DO - 10.1053/rvsc.1999.0327 ID - Martín De Las Mulas2000 ER - TY - JOUR AU - Mulas JM, D. l. AU - van Niel, M. AU - Millán, Y. AU - Blankenstein, M. A. AU - Van Mil, F. AU - Misdorp, W. PY - 2000 DA - 2000// TI - Immunohistochemical analysis of estrogen receptors in feline mammary gland benign and malignant lesions: comparison with biochemical assay JO - Domest Anim Endocrinol VL - 18 UR - https://doi.org/10.1016/S0739-7240(99)00067-3 DO - 10.1016/S0739-7240(99)00067-3 ID - Mulas JM2000 ER - TY - JOUR AU - De Maria, R. AU - Olivero, M. AU - Iussich, S. AU - Nakaichi, M. AU - Murata, T. AU - Biolatti, B. AU - Di Renzo, M. F. PY - 2005 DA - 2005// TI - Spontaneous feline mammary carcinoma is a model of HER2 overexpressing poor prognosis human breast cancer JO - Cancer Res VL - 65 ID - De Maria2005 ER - TY - JOUR AU - Millanta, F. AU - Calandrella, M. AU - Vannozzi, I. AU - Poli, A. PY - 2006 DA - 2006// TI - Steroid hormone receptors in normal, dysplastic and neoplastic feline mammary tissues and their prognostic significance JO - Vet Rec VL - 158 UR - https://doi.org/10.1136/vr.158.24.821 DO - 10.1136/vr.158.24.821 ID - Millanta2006 ER - TY - JOUR AU - Martín De Las Mulas, J. M. AU - Van Niel, M. AU - Millan, Y. AU - Ordas, J. AU - Blankenstein, M. A. AU - Van Mil, F. AU - Misdorp, W. PY - 2002 DA - 2002// TI - Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status JO - Res Vet Sci VL - 72 UR - https://doi.org/10.1053/rvsc.2001.0542 DO - 10.1053/rvsc.2001.0542 ID - Martín De Las Mulas2002 ER - TY - JOUR AU - Maniscalco, L. AU - Iussich, S. AU - de Las Mulas, J. M. AU - Millán, Y. AU - Biolatti, B. AU - Sasaki, N. AU - Nakagawa, T. AU - De Maria, R. PY - 2012 DA - 2012// TI - Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours JO - Vet J VL - 191 UR - https://doi.org/10.1016/j.tvjl.2010.12.016 DO - 10.1016/j.tvjl.2010.12.016 ID - Maniscalco2012 ER - TY - JOUR AU - Millanta, F. AU - Calandrella, M. AU - Citi, S. AU - Della Santa, D. AU - Poli, A. PY - 2005 DA - 2005// TI - Overexpression of HER-2 in feline invasive mammary carcinomas: an immunohistochemical survey and evaluation of its prognostic potential JO - Vet Pathol VL - 42 UR - https://doi.org/10.1354/vp.42-1-30 DO - 10.1354/vp.42-1-30 ID - Millanta2005 ER - TY - JOUR AU - Onitilo, A. A. AU - Engel, J. M. AU - Greenlee, R. T. AU - Mukesh, B. N. PY - 2009 DA - 2009// TI - Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival JO - Clin Med Res VL - 7 UR - https://doi.org/10.3121/cmr.2008.825 DO - 10.3121/cmr.2008.825 ID - Onitilo2009 ER - TY - JOUR AU - Rasotto, R. AU - Caliari, D. AU - Castagnaro, M. AU - Zanetti, R. AU - Zappulli, V. PY - 2011 DA - 2011// TI - An Immunohistochemical study of HER-2 expression in feline mammary tumours JO - J Comp Pathol VL - 144 UR - https://doi.org/10.1016/j.jcpa.2010.08.010 DO - 10.1016/j.jcpa.2010.08.010 ID - Rasotto2011 ER - TY - BOOK AU - Misdorp, W. AU - Else, R. W. AU - Hellmen, E. AU - Lipscomb, T. P. PY - 1999 DA - 1999// TI - Histological Classification of Mammary Tumors of the Dog and the Cat PB - Armed Forces Institute of Pathology CY - Washington, D.C. ID - Misdorp1999 ER - TY - JOUR AU - Castagnaro, M. AU - Casalone, C. AU - Bozzetta, E. AU - De Maria, R. AU - Biolatti, B. AU - Caramelli, M. PY - 1998 DA - 1998// TI - Tumour grading and the one-year post-surgical prognosis in feline mammary carcinomas JO - J Comp Pathol VL - 119 UR - https://doi.org/10.1016/S0021-9975(98)80049-2 DO - 10.1016/S0021-9975(98)80049-2 ID - Castagnaro1998 ER - TY - JOUR AU - Albert, J. M. AU - Kim, K. W. AU - Cao, C. AU - Lu, B. PY - 2006 DA - 2006// TI - Targeting the Akt/mammalian target of rapamycin pathway for radiosensitization of breast cancer JO - Mol Cancer Ther VL - 5 UR - https://doi.org/10.1158/1535-7163.MCT-05-0400 DO - 10.1158/1535-7163.MCT-05-0400 ID - Albert2006 ER - TY - JOUR AU - Ordas, J. AU - Millan, Y. AU - Dios, R. AU - Reymundo, C. AU - Mulas JM, D. l. PY - 2007 DA - 2007// TI - Proto-oncogene HER-2 in normal, dysplastic and tumorous feline mammary glands: an immunohistochemical and chromogenic in situ hybridization study JO - BMC Cancer VL - 7 UR - https://doi.org/10.1186/1471-2407-7-179 DO - 10.1186/1471-2407-7-179 ID - Ordas2007 ER - TY - JOUR AU - Takauji, S. R. AU - Watanabe, M. AU - Uyama, R. AU - Nakagawa, T. AU - Miyajima, N. AU - Mochizuki, M. AU - Nishimura, R. AU - Sugano, S. AU - Sasaki, N. PY - 2007 DA - 2007// TI - Expression and subcellular localization of E-cadherin, alpha-catenin, and beta-catenin in 8 feline mammary tumor cell lines JO - J Vet Med Sci VL - 69 UR - https://doi.org/10.1292/jvms.69.831 DO - 10.1292/jvms.69.831 ID - Takauji2007 ER - TY - JOUR AU - Minke, J. M. AU - Weijer, K. AU - Misdorp, W. PY - 1991 DA - 1991// TI - Allotransplantation of K248 feline mammary carcinoma cell line in cats, A model for monoclonal antibody guided detection and therapy of human breast cancer JO - Lab Invest VL - 65 ID - Minke1991 ER - TY - JOUR AU - Muleya, J. S. AU - Nakaichi, M. AU - Sugahara, J. AU - Taura, Y. AU - Murata, T. AU - Nakama, S. PY - 1998 DA - 1998// TI - Establishment and characterization of a new cell line derived from feline mammary tumor JO - J Vet Med Sci VL - 60 UR - https://doi.org/10.1292/jvms.60.931 DO - 10.1292/jvms.60.931 ID - Muleya1998 ER - TY - JOUR AU - Muleya, J. S. AU - Nakaichi, M. AU - Taura, Y. AU - Yamaguchi, R. AU - Nakama, S. PY - 1999 DA - 1999// TI - In-vitro anti-proliferative effects of some anti-tumour drugs on feline mammary tumour cell lines JO - Res Vet Sci VL - 66 UR - https://doi.org/10.1053/rvsc.1998.0218 DO - 10.1053/rvsc.1998.0218 ID - Muleya1999 ER - TY - JOUR AU - Uyama, R. AU - Hong, S. H. AU - Nakagawa, T. AU - Yazawa, M. AU - Kadosawa, T. AU - Mochizuki, M. AU - Tsujimoto, H. AU - Nishimura, R. AU - Sasaki, N. PY - 2005 DA - 2005// TI - Establishment and characterization of eight feline mammary adenocarcinoma cell lines JO - J Vet Med Sci VL - 67 UR - https://doi.org/10.1292/jvms.67.1273 DO - 10.1292/jvms.67.1273 ID - Uyama2005 ER - TY - JOUR AU - Carey, L. AU - Winer, E. AU - Viale, G. AU - Cameron, D. AU - Gianni, L. PY - 2010 DA - 2010// TI - Triple-negative breast cancer: disease entity or title of convenience? JO - Nat Rev Clin Oncol VL - 7 UR - https://doi.org/10.1038/nrclinonc.2010.154 DO - 10.1038/nrclinonc.2010.154 ID - Carey2010 ER - TY - JOUR AU - Eiermann, W. AU - Bergh, J. AU - Cardoso, F. AU - Conte, P. AU - Crown, J. AU - Curtin, N. J. AU - Gligorov, J. AU - Gusterson, B. AU - Joensuu, H. AU - Linderholm, B. K. PY - 2012 DA - 2012// TI - Triple negative breast cancer: proposals for a pragmatic definition and implications for patient management and trial design JO - Breast VL - 21 UR - https://doi.org/10.1016/j.breast.2011.09.006 DO - 10.1016/j.breast.2011.09.006 ID - Eiermann2012 ER - TY - JOUR AU - Yunokawa, M. AU - Koizumi, F. AU - Kitamura, Y. AU - Katanasaka, Y. AU - Okamoto, N. AU - Kodaira, M. AU - Yonemori, K. AU - Shimizu, C. AU - Ando, M. AU - Masutomi, K. PY - 2012 DA - 2012// TI - Efficacy of everolimus, a novel mTOR inhibitor, against basal-like triple-negative breast cancer cells JO - Cancer Sci VL - 103 UR - https://doi.org/10.1111/j.1349-7006.2012.02359.x DO - 10.1111/j.1349-7006.2012.02359.x ID - Yunokawa2012 ER - TY - JOUR AU - Hughes, K. AU - Dobson, J. M. PY - 2012 DA - 2012// TI - Prognostic histopathological and molecular markers in feline mammary neoplasia JO - Vet J VL - 194 UR - https://doi.org/10.1016/j.tvjl.2012.05.008 DO - 10.1016/j.tvjl.2012.05.008 ID - Hughes2012 ER - TY - JOUR AU - Chen, Y. -. T. AU - Tan, K. A. L. AU - Pang, L. Y. AU - Argyle, D. J. PY - 2012 DA - 2012// TI - The class I PI3K/Akt pathway is critical for cancer cell survival in dogs and offers an opportunity for therapeutic intervention JO - BMC Vet Res VL - 8 UR - https://doi.org/10.1186/1746-6148-8-73 DO - 10.1186/1746-6148-8-73 ID - Chen2012 ER - TY - CHAP AU - Nakajima, H. AU - Ishikawa, Y. AU - Furuya, M. AU - Sano, T. AU - Ohno, Y. AU - Horiguchi, J. AU - Oyama, T. PY - 2012 DA - 2012// TI - Protein expression, gene amplification, and mutational analysis of EGFR in triple-negative breast cancer BT - Breast Cancer ID - Nakajima2012 ER - TY - JOUR AU - Noh, W. C. AU - Kim, Y. H. AU - Kim, M. S. AU - Koh, J. S. AU - Kim, H. A. AU - Moon, N. M. AU - Paik, N. S. PY - 2008 DA - 2008// TI - Activation of the mTOR signaling pathway in breast cancer and its correlation with the clinicopathologic variables JO - Breast Cancer Res Treat VL - 110 UR - https://doi.org/10.1007/s10549-007-9746-x DO - 10.1007/s10549-007-9746-x ID - Noh2008 ER - TY - JOUR AU - Rajagopalan, H. AU - Bardelli, A. AU - Lengauer, C. AU - Kinzler, K. W. AU - Vogelstein, B. AU - Velculescu, V. E. PY - 2002 DA - 2002// TI - Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status JO - Nature VL - 418 UR - https://doi.org/10.1038/418934a DO - 10.1038/418934a ID - Rajagopalan2002 ER - TY - JOUR AU - Gorden, A. AU - Osman, I. AU - Gai, W. AU - He, D. AU - Huang, W. AU - Davidson, A. AU - Houghton, A. N. AU - Busam, K. AU - Polsky, D. PY - 2003 DA - 2003// TI - Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues JO - Cancer Res VL - 63 ID - Gorden2003 ER - TY - JOUR AU - Willems, L. AU - Tamburini, J. AU - Chapuis, N. AU - Lacombe, C. AU - Mayeux, P. AU - Bouscary, D. PY - 2012 DA - 2012// TI - PI3K and mTOR signaling pathways in cancer: new data on targeted therapies JO - Curr Oncol Rep VL - 14 UR - https://doi.org/10.1007/s11912-012-0227-y DO - 10.1007/s11912-012-0227-y ID - Willems2012 ER -